ICD-10 Coding for Neutropenia(A41.9, A41.9U, D70.0)
Comprehensive guide to ICD-10 coding for neutropenia, including chemotherapy and infection-induced cases. Learn about documentation requirements and coding pitfalls.
Complete code families applicable to Neutropenia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D70.0 | Agranulocytosis | Use when agranulocytosis is confirmed by lab tests and clinical evaluation. |
|
| D70.1 | Agranulocytosis secondary to chemotherapy | Use when neutropenia is a direct result of chemotherapy treatment. |
|
| D70.3 | Neutropenia due to infection | Use when neutropenia is caused by an infectious process. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutNeutropenia
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Neutropenia.
Failing to document chemotherapy as the cause of neutropenia
Impact
Clinical: Misleading clinical picture, Regulatory: Non-compliance with coding standards, Financial: Potential loss of reimbursement
Mitigation
Ensure chemotherapy details are included in patient records, Regular audits of oncology documentation
Using unspecified codes when specific ones apply
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of health data.
Mitigation
Ensure documentation supports the most specific code available.
Use of unspecified codes
Impact
High risk of audit if unspecified codes are used without justification.
Mitigation
Ensure all documentation supports the most specific code available.